Samsca (or tolvaptan) is a widely-prescribed medication used to treat hyponatremia (low levels of sodium in the blood) in patients with heart failure, liver disease, and certain hormonal imbalances. According to a January 2013 warning issued by the FDA, a number of Samsca users have reported developing elevated serum enzyme levels in the liver, a condition indicative of a diseased or damaged liver. If you or someone you know has taken Samsca and been diagnosed with a severe liver injury, or an exacerbated liver injury, call me today. You may be entitled to compensation.
Samsca Linked to Liver Injuries
Categories: Bad Drug Newsletter